Ibotta, Inc.
NYSE:IBTASoftware - Application
-$0.19 today
- Market cap
- $1.16B
- Beta
- -0.58
- P/E (TTM)
- -96.1
- EPS (TTM)
- -$0.30
Volume 0.45M
Average 0.22M
IBTA Operating Expenses
Total costs of running the business that are not directly tied to producing goods or services sold.
Ibotta, Inc.NYSE: IBTA
Operating Expenses · Q1 FY2026 · quarter ended Mar 2026
Operating expenses growth accelerates
Q1 FY2026 operating expenses of $72.31M rose 2.9% year over year, ahead of the -9.7% change in trailing-twelve-month operating expenses. Sequentially, it rose 0.6% from the prior quarter. Over 3 fiscal years it compounded at +9.6% a year.
Context
- Operating expenses amounted to 77.6% of revenue in FY2025, down 1.1 pp from a year earlier.
- Operating expenses increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth of +2.9% holds above the trailing-twelve-month pace of -9.7%.
Sources:Income StatementText generated from reported figures; not investment advice.
Operating Expenses history
USD · from the income statement
- Latest · FY2025
- 265.77M USD
- Year-over-year change
- -8.1%
- 3-year CAGR
- +9.6%
| Period | Period end | Operating Expenses | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 265.77M | -8.1% |
| FY2024 | 2024-12-31 | 289.21M | +33.7% |
| FY2023 | 2023-12-31 | 216.39M | +7.2% |
| FY2022 | 2022-12-31 | 201.79M | — |
Operating Expenses vs competitors
How IBTA compares with its peers on the latest reported figures
- Peers report in different currencies, so operating expenses is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -9.7% is the 7th highest of 10, against a peer median of -6.1%.
- Operating expenses amounts to 80.6% of revenue for IBTA, versus a peer median of 62.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | CN¥4.12B CNY | -12.6% | +3.3% | 32.3% | |
| LTM Mar 2026 | $381.26M USD | +24.9% | +0.9% | 62.6% | |
| LTM Mar 2026 | $274.2M USD | -9.7% | +9.6% | 80.6% | |
| LTM Mar 2026 | $240.6M USD | -12.4% | -4.2% | 42.6% | |
| LTM Mar 2026 | $204.96M USD | -6.1% | -5.7% | 58.5% | |
| LTM Mar 2026 | $177.59M USD | +8.9% | +15.5% | 70.8% | |
| LTM Mar 2026 | $168.65M USD | +5.6% | +2.8% | 68.3% | |
| LTM Mar 2026 | $113.98M USD | -9.5% | -48.8% | 89.3% | |
| LTM Mar 2026 | $67.42M USD | -13.9% | +12.2% | 62.3% | |
| LTM Mar 2026 | $64.88M USD | +16.6% | +15.3% | 69.0% | |
| Peer median (excluding IBTA) | — | -6.1% | +2.8% | 62.6% | |
Competitors are the stored peer set for IBTA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|
| Revenue | 210.7M | 320.04M | 367.25M | 342.39M |
| Cost of Revenue | 49.22M | 47.65M | 50.12M | 74.97M |
| Gross Profit | 161.48M | 272.38M | 317.13M | 267.42M |
| Gross Margin | 76.6% | 85.1% | 86.4% | 78.1% |
| Research & Development | 42.56M | 50M | 63.27M | 61.08M |
| Selling, General & Admin | 159.23M | 166.39M | 221.95M | 207.18M |
| Operating Expenses | 201.79M | 216.39M | 289.21M | 265.77M |
| Depreciation & Amortization | 6.32M | 6.66M | 8.08M | 8.32M |
| EBITDA | (42.97M) | 57.6M | 32.58M | 18.17M |
| EBITDA Margin | -20.4% | 18.0% | 8.9% | 5.3% |
| Operating Income | (40.31M) | 56M | 27.93M | 1.66M |
| Operating Margin | -19.1% | 17.5% | 7.6% | 0.5% |
| Interest Income | 0 | 0 | 9.41M | 10.78M |
| Interest Expense | 5.31M | 6.88M | 0 | 0 |
| Other Income / Expenses | (14.29M) | (11.95M) | (3.43M) | 8.19M |
| Income Before Tax | (54.6M) | 44.05M | 24.5M | 9.85M |
| Pre-Tax Margin | -25.9% | 13.8% | 6.7% | 2.9% |
| Income Tax Expense | 262K | 5.93M | (44.25M) | 6.27M |
| Net Income | (54.86M) | 38.12M | 68.74M | 3.58M |
| Net Margin | -26.0% | 11.9% | 18.7% | 1.0% |
| EPS (Basic) | (1.81) | 1.26 | 2.85 | 0.13 |
| EPS (Diluted) | (1.81) | 1.26 | 2.56 | 0.12 |
| Weighted Avg Shares | 30.24M | 30.24M | 24.12M | 28.37M |
| Weighted Avg Shares (Diluted) | 30.24M | 30.24M | 26.86M | 30.1M |
Ibotta, Inc.
NYSE:IBTA
Intrinsic Alpha fair value
Locked
Current Price
$56.87
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.